SCHEMBL28890957

SCHEMBL28890957

CCOc1ccc(S(=O)(=O)O)cc1-c1nn2c(C)nc(C)c2c(=O)[nH]1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 20/20 0.73
PDE1A P54750 9/20 0.73
PDE1B Q01064 9/20 0.73
PDE1C Q14123 9/20 0.73
PDE4B Q07343 2/20 0.61
PDE6A P16499 2/20 0.61
PDE2A O00408 1/20 0.61
PDE6D O43924 1/20 0.61
PDE9A O76083 1/20 0.61
CHRM2 P08172 1/20 0.61
ADORA3 P0DMS8 1/20 0.61
PDE6G P18545 1/20 0.61
MAOA P21397 1/20 0.61
PDE4A P27815 1/20 0.61
ADORA1 P30542 1/20 0.61
ADRA1A P35348 1/20 0.61
PDE6B P35913 1/20 0.61
PDE6C P51160 1/20 0.61
SLC6A3 Q01959 1/20 0.61
PDE4C Q08493 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL973746 0.90 PDE5A (0.68) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL7389060 0.90 PDE5A (0.68) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL5767555 0.89 PDE5A (0.77) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL29663760 0.89 PDE5A (0.77) PDE5APDE1APDE1BPDE1CPDE4B
Hydrochloric Acid SCHEMBL18167456 0.88 PDE5A (0.77) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL974080 0.88 PDE5A (0.65) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL13384838 0.88 PDE5A (0.82) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL974965 0.86 PDE5A (0.83) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL973698 0.86 PDE5A (0.77) PDE5APDE1APDE1BPDE1CPDE4B
SCHEMBL973597 0.86 PDE5A (0.77) PDE5APDE1APDE1BPDE1CPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 CN claimed
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 CN disclosed